Aprepitant and Ethynodiol: Interaction Details
- Aprepitant
- EmendCinvantiAponvie
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Aprepitant and Ethynodiol interaction:
Aprepitant
- Emend
- Cinvanti
- Aponvie
Ethynodiol
We don't have a drug information page for Ethynodiol yet. Have a question about Ethynodiol? Ask a pharmacist, free →
What Happens When You Take Aprepitant With Ethynodiol
What can happen when they are taken together (rated Major)
Reduced hormonal contraceptive exposure, reduced of hormonal contraceptives and an increased risk of breakthrough bleeding/contraceptive failure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When aprepitant or fosaprepitant is given together with hormonal contraceptives, exposure to the contraceptive may fall, which can weaken its efficacy and result in breakthrough bleeding or contraceptive failure. Studies of showed marked reductions in both the and the trough concentration of ethinyl estradiol and norethindrone. Patients should be told to rely on an alternative or additional contraceptive method throughout treatment and for 1 month following the final dose of fosaprepitant or oral aprepitant.123
The Aprepitant and Ethynodiol Interaction, Explained
Aprepitant (Emend, Cinvanti) is used to prevent nausea and vomiting, often with chemotherapy or surgery. Ethynodiol is a birth control pill ingredient, and it is usually paired with ethinyl estradiol. Aprepitant can speed up how your body breaks down the estrogen part of the pill, so there may be less hormone in your system. That could make the pill work less well and may cause spotting or breakthrough bleeding.
The evidence for this is labeled theoretical, but aprepitant's label advises backup protection anyway. Please keep taking your pill as prescribed and ask your pharmacist or doctor about using a backup method, such as condoms, during treatment and for 1 month after your last dose. Your care team can help you plan this.
Mechanism: Aprepitant induces (and ), which may increase of ethinyl estradiol, the estrogen component paired with ethynodiol diacetate. This lowers hormonal exposure. Neither drug's effect depends on activation in a way that changes the direction here.
- Direction: decreased contraceptive hormone exposure, risk of breakthrough bleeding and contraceptive failure.
- Data: studies of aprepitant with ethinyl estradiol and norethindrone showed significant decreases in and trough concentration. The rating on file is theoretical for this specific pairing.
- Onset: delayed.
- Management: advise effective alternative or back-up contraception during therapy and for 1 month after the last dose of oral aprepitant or fosaprepitant.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Aprepitant and Ethynodiol Interact
The likely mechanism
of -mediated of ethinyl estradiol
How to Manage the Aprepitant and Ethynodiol Interaction
Your care team typically handles this by adding a backup or alternative birth control method rather than changing your medicines.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Use an effective backup method during aprepitant or fosaprepitant treatment and for 1 month after the last dose.
- Tell your pharmacist or prescriber about all hormonal contraceptives you use, and mention any new spotting or breakthrough bleeding.
- Ask your care team if you have questions about which backup method suits you.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Aprepitant or Ethynodiol need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: EMEND intravenous injection, fosaprepitant intravenous injection
In a study where oral aprepitant 100 mg was administered once daily for 14 days together with an oral contraceptive containing ethinyl estradiol 35 mcg and norethindrone 1 mg, the of ethinyl estradiol fell by 43% and the AUC of norethindrone fell by 8%. In a separate study, a combination contraceptive containing ethinyl estradiol and norethindrone was given daily for 21 days.
On day 8, patients received oral aprepitant 125 mg, intravenous ondansetron 32 mg, and oral dexAMETHasone 12 mg. On days 9 and 10, oral aprepitant 80 mg/day and dexAMETHasone 8 mg/day were given, and on day 11 oral dexAMETHasone 8 mg was given by itself.
On day 10, the ethinyl estradiol AUC was reduced by 19%, while the norethindrone AUC was unchanged. Across days 9 through 21, trough concentrations of ethinyl estradiol declined by up to 64% and those of norethindrone declined by up to 60%.1
Aprepitant and Ethynodiol: Common Questions
How serious is the Aprepitant and Ethynodiol interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Aprepitant and Ethynodiol interaction managed?
Your care team typically handles this by adding a backup or alternative birth control method rather than changing your medicines. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Use an effective backup method during aprepitant or fosaprepitant treatment and for 1 month after the last dose. Tell your pharmacist or prescriber about all hormonal contraceptives you… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Aprepitant with Ethynodiol?
Your care team typically handles this by adding a backup or alternative birth control method rather than changing your medicines.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Aprepitant and Ethynodiol Interaction
Ask in your own words about taking Aprepitant and Ethynodiol together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: EMEND(R) intravenous injection, fosaprepitant intravenous injection. Merck Sharp & Dohme Corp (per FDA), Whitehouse Station, NJ, 2022. DailyMed
- Product Information: FOCINVEZ intravenous injection, fosaprepitant intravenous injection. Spes Pharmaceuticals Inc (per FDA), North Brunswick, NJ, 2023. DailyMed
- Product Information: NuvaRing(R) vaginal ring, etonogestrel ethinyl estradiol vaginal ring. Organon & Co. (per FDA), Jersey City, NJ, 2024.
Other Serious Interactions of Aprepitant and Ethynodiol
Also serious with Aprepitant
- FlibanserinContraindicated
- LevoketoconazoleContraindicated
- LomitapideContraindicated
- PimozideContraindicated
Also serious with Ethynodiol
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Aprepitant
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.